Use of Anti-IL-20 antibody for treating osteoporosis (as amended)

Ming-Shi Chang

Use of Anti-IL-20 antibody for treating osteoporosis (as amended)

Ming-Shi Chang (Inventor)

生物化學暨分子生物學研究所

研究成果: Patent

摘要

Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.

原文	English
專利號	7837994
出版狀態	Published - 2010 4月 8

引用此

@misc{8a4c58db2ffc4744befddfcd245e80d6,

title = "Use of Anti-IL-20 antibody for treating osteoporosis (as amended)",

abstract = "Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.",

author = "Ming-Shi Chang",

year = "2010",

month = apr,

day = "8",

language = "English",

type = "Patent",

note = "7837994",

}

TY - PAT

T1 - Use of Anti-IL-20 antibody for treating osteoporosis (as amended)

AU - Chang, Ming-Shi

PY - 2010/4/8

Y1 - 2010/4/8

N2 - Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.

AB - Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.

M3 - Patent

M1 - 7837994

ER -

Use of Anti-IL-20 antibody for treating osteoporosis (as amended)

摘要

指紋

引用此